ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
8.67
-0.29 (-3.24%)
At close: Mar 6, 2026, 4:00 PM EST
8.64
-0.03 (-0.35%)
After-hours: Mar 6, 2026, 7:59 PM EST
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $8.91 billion as of March 6, 2026. Its market cap has increased by 235.38% in one year.
Market Cap
8.91B
Enterprise Value
9.52B
1-Year Change
235.38%
Ranking
Category
Stock Price
$8.67
Market Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from $14.82B to $8.91B, a decrease of -39.87%. That is a compound annual growth rate of -9.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 8.91B | 357.06% |
| Dec 31, 2025 | 1.95B | 4.33% |
| Dec 31, 2024 | 1.87B | -44.23% |
| Dec 29, 2023 | 3.35B | 61.49% |
| Dec 30, 2022 | 2.08B | -14.18% |
| Dec 31, 2021 | 2.42B | -83.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exelixis | 10.72B |
| Madrigal Pharmaceuticals | 10.08B |
| ABIVAX Société Anonyme | 8.92B |
| Arrowhead Pharmaceuticals | 8.91B |
| Bio-Techne | 8.74B |
| Praxis Precision Medicines | 8.65B |
| Vaxcyte | 8.38B |
| Axsome Therapeutics | 8.26B |